Minimal Transaction Requirements :
- Drug Development -2M euro, protected IP, Proof of concept in animals.
- Medtech:-2 M euro, working Beta prototype, protected IP.
- Our experience ranges from start-ups and spin-offs to PIPE in NASDAQ quoted Companies, phase III transactions.
- We have also done fundraising for incubators, funds and operations between funds specialized in Life Sciences.
- Company funded in 2003
Who are our clients
Kerentech renders services to companies looking for fundraising in the form of:
- Venture capital
- Business Angels
- Co-development agreements
- Joint ventures
- Participative loans
- Patent financing
As well as to investors raising funds to invest ( incubators, VCs), or co-investors for their portfolio Companies.
Conditions and agreements
- Only the client company has the right to conduct negotiation with any investor introduced by Kerentech
- Only the client company has the right to accept or reject any proposal or investor introduced by Kerentech
- Kerentech will not render similar services to any company which directly competes with its client.
- Kerentech will not forward any confidential information of its client without first obtaining a signed non-disclosure agreement from the possible investor
- The terms for the contract will be agreed by both companies